Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (219) 219
Publication (54) 54
Newspaper Article (12) 12
Patent (5) 5
Book Chapter (4) 4
Magazine Article (3) 3
Book / eBook (2) 2
Book Review (2) 2
Conference Proceeding (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (119) 119
index medicus (86) 86
male (73) 73
child (72) 72
female (69) 69
gastroenterology & hepatology (64) 64
adolescent (58) 58
pediatrics (52) 52
article (50) 50
fatty liver (38) 38
liver - pathology (37) 37
liver diseases (37) 37
steatohepatitis (36) 36
prevalence (35) 35
children (32) 32
gastroenterology and hepatology (32) 32
obesity (31) 31
adult (30) 30
nonalcoholic steatohepatitis (29) 29
fatty liver - pathology (27) 27
risk factors (27) 27
abridged index medicus (26) 26
fibrosis (26) 26
metabolic syndrome (26) 26
biopsy (25) 25
non-alcoholic fatty liver disease (24) 24
middle aged (23) 23
nonalcoholic fatty liver disease (21) 21
child, preschool (19) 19
insulin-resistance (19) 19
adolescents (18) 18
hepatic steatosis (17) 17
fatty liver - etiology (16) 16
alanine transaminase - blood (15) 15
cross-sectional studies (15) 15
fatty liver - diagnosis (15) 15
health aspects (15) 15
obese children (15) 15
care and treatment (14) 14
fatty liver-disease (14) 14
infant (14) 14
nafld (14) 14
non-alcoholic fatty liver disease - pathology (14) 14
united-states (14) 14
vitamin-e (14) 14
analysis (13) 13
liver (13) 13
nutrition & dietetics (13) 13
obesity - complications (13) 13
prospective studies (13) 13
fatty liver - epidemiology (12) 12
fatty liver - therapy (12) 12
nutritional and metabolic diseases (12) 12
severity of illness index (12) 12
diagnosis (11) 11
diet (11) 11
digestive system (11) 11
digestive system diseases (11) 11
insulin resistance (11) 11
retrospective studies (11) 11
vitamin e - therapeutic use (11) 11
animals (10) 10
cirrhosis (10) 10
diabetes (10) 10
disease (10) 10
fatty liver - metabolism (10) 10
liver cirrhosis - pathology (10) 10
medical research (10) 10
risk (10) 10
steatosis (10) 10
association (9) 9
fatty liver - physiopathology (9) 9
histology (9) 9
medicine, experimental (9) 9
nash (9) 9
radiology, nuclear medicine & medical imaging (9) 9
research (9) 9
risk-factors (9) 9
united states - epidemiology (9) 9
aged (8) 8
alanine aminotransferase (8) 8
antioxidants - therapeutic use (8) 8
chronic hepatitis-c (8) 8
clinical trials (8) 8
double-blind method (8) 8
fatty liver - blood (8) 8
fatty liver - drug therapy (8) 8
genetic predisposition to disease (8) 8
hepatocellular-carcinoma (8) 8
hypoglycemic agents - therapeutic use (8) 8
infant, newborn (8) 8
inflammation (8) 8
life style (8) 8
liver - metabolism (8) 8
liver transplantation (8) 8
mortality (8) 8
non-alcoholic fatty liver disease - therapy (8) 8
pediatric (8) 8
transplantation (8) 8
treatment outcome (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Pediatric liver disease
by Lavine, Joel E and Jonas, Maureen M
1994, Seminars in liver disease, Volume 14, no. 3., 213-317.
Book
Details down arrow
2. Full Text Pediatric Liver Diseases
by Lavine, Joel E
Seminars in Liver Disease, ISSN 0272-8087, 11/2012, Volume 32, Issue 4, pp. 271 - 272
Foreword | Liver Diseases | Child | Humans
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
by Chalasani, Naga and Younossi, Zobair and Lavine, Joel E and Charlton, Michael and Cusi, Kenneth and Rinella, Mary and Harrison, Stephen A and Brunt, Elizabeth M and Sanyal, Arun J
Hepatology, ISSN 0270-9139, 01/2018, Volume 67, Issue 1, pp. 328 - 357
HEPATOCELLULAR-CARCINOMA HCC | ACTIVATED-RECEPTOR-ALPHA | VITAMIN-E | LONG-TERM OUTCOMES | MODERATE ALCOHOL-CONSUMPTION | BARIATRIC SURGERY | SEVERE MUSCLE DEPLETION | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | GASTROENTEROLOGY & HEPATOLOGY | INSULIN-SENSITIZING AGENTS | Liver Transplantation | Prevalence | Obesity - complications | Humans | Non-alcoholic Fatty Liver Disease - therapy | Incidence | Mass Screening | Adolescent | Non-alcoholic Fatty Liver Disease - diagnosis | Adult | Disease Management | Child | Non-alcoholic Fatty Liver Disease - epidemiology | Liver diseases | Fatty liver
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
by Sanyal, Arun J and Chalasani, Naga and Kowdley, Kris V and McCullough, Arthur and Diehl, Anna Mae and Bass, Nathan M and Neuschwander-Tetri, Brent A and Lavine, Joel E and Tonascia, James and Unalp, Aynur and Van Natta, Mark and Clark, Jeanne and Brunt, Elizabeth M and Kleiner, David E and Hoofnagle, Jay H and Robuck, Patricia R and NASH CRN
The New England Journal of Medicine, ISSN 0028-4793, 05/2010, Volume 362, Issue 18, pp. 1675 - 1685
In this randomized trial comparing vitamin E, pioglitazone, and placebo in adults without diabetes who had nonalcoholic steatohepatitis, vitamin E therapy was... 
VARIABILITY | MEDICINE, GENERAL & INTERNAL | NAFLD | METAANALYSIS | STEATOSIS | FATTY LIVER-DISEASE | FOLLOW-UP | HISTORY | Hypoglycemic Agents - therapeutic use | Liver - pathology | Double-Blind Method | Fatty Liver - pathology | Fatty Liver - physiopathology | Humans | Middle Aged | Insulin Resistance | Male | Vitamin E - adverse effects | Chi-Square Distribution | Thiazolidinediones - adverse effects | Fatty Liver - drug therapy | Antioxidants - therapeutic use | Thiazolidinediones - therapeutic use | Intention to Treat Analysis | Vitamin E - therapeutic use | Adult | Antioxidants - adverse effects | Female | Transaminases - blood | Weight Gain - drug effects | Hypoglycemic Agents - adverse effects | Oxidative stress | Liver diseases | Drug therapy | Health aspects | Insulin resistance | Diabetes | Disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Dietary fructose in nonalcoholic fatty liver disease
by Miriam B. Vos and Joel E. Lavine
Hepatology, ISSN 0270-9139, 06/2013, Volume 57, Issue 6, p. 2525
  Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in adults and children. A number of genetic and environmental factors are... 
Liver diseases | Hepatology | Insulin resistance | Liver cirrhosis
Journal Article
Details down arrow
6. Full Text Dietary fructose in nonalcoholic fatty liver disease
by Vos, Miriam B and Lavine, Joel E
Hepatology, ISSN 0270-9139, 06/2013, Volume 57, Issue 6, pp. 2525 - 2531
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in adults and children. A number of genetic and environmental factors are... 
METABOLIC SYNDROME | OBESE ADOLESCENTS | HEALTHY-SUBJECTS | DENSITY-LIPOPROTEIN | VISCERAL ADIPOSITY | OVERWEIGHT/OBESE HUMANS | CORN SYRUP | GASTROENTEROLOGY & HEPATOLOGY | INSULIN SENSITIVITY | GLUCOSE-SWEETENED BEVERAGES | URIC-ACID | Animals | Fructose - adverse effects | Humans | Liver - metabolism | Dietary Carbohydrates - adverse effects | Lipogenesis | Fatty Liver - etiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
by Chalasani, Naga and Younossi, Zobair and Lavine, Joel E and Diehl, Anna Mae and Brunt, Elizabeth M and Cusi, Kenneth and Charlton, Michael and Sanyal, Arun J
Hepatology, ISSN 0270-9139, 06/2012, Volume 55, Issue 6, pp. 2005 - 2023
ALL-CAUSE MORTALITY | LIFE-STYLE INTERVENTION | PLACEBO-CONTROLLED-TRIAL | CHRONIC HEPATITIS-C | MODERATE ALCOHOL-CONSUMPTION | POPULATION-BASED COHORT | RANDOMIZED CONTROLLED-TRIAL | VITAMIN-E SUPPLEMENTATION | GASTROENTEROLOGY & HEPATOLOGY | TYPE-2 DIABETES-MELLITUS | INSULIN-SENSITIZING AGENTS | Life Style | Thiazolidinediones - therapeutic use | Fatty Liver - diagnosis | Metformin - therapeutic use | Prevalence | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Risk Factors | Non-alcoholic Fatty Liver Disease | Vitamin E - therapeutic use | Fatty Liver - therapy | Fatty Liver - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
by Neuschwander-Tetri, Brent A, Prof and Loomba, Rohit, MD and Sanyal, Arun J, Prof and Lavine, Joel E, Prof and Van Natta, Mark L, MHS and Abdelmalek, Manal F, MD and Chalasani, Naga, Prof and Dasarathy, Srinivasan, MD and Diehl, Anna Mae, Prof and Hameed, Bilal, MD and Kowdley, Kris V, Prof and McCullough, Arthur, Prof and Terrault, Norah, Prof and Clark, Jeanne M, Prof and Tonascia, James, Prof and Brunt, Elizabeth M, Prof and Kleiner, David E, MD and Doo, Edward, MD and Nash Clin Res Network and NASH Clinical Research Network
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9972, pp. 956 - 965
Summary Background The bile acid derivative 6-ethylchenodeoxycholic acid (obeticholic acid) is a potent activator of the farnesoid X nuclear receptor that... 
Internal Medicine | FXR | MEDICINE, GENERAL & INTERNAL | NAFLD | THERAPY | GLUCOSE-METABOLISM | FATTY LIVER-DISEASE | INSULIN-RESISTANCE | RATS | NASH | BILE-ACIDS | AGONIST | Liver Cirrhosis - drug therapy | Liver - enzymology | Double-Blind Method | Administration, Oral | Cholesterol, HDL - metabolism | Receptors, Cytoplasmic and Nuclear - drug effects | Humans | Middle Aged | Male | Treatment Outcome | Chenodeoxycholic Acid - administration & dosage | Weight Loss - drug effects | Chenodeoxycholic Acid - analogs & derivatives | Non-alcoholic Fatty Liver Disease - drug therapy | Chenodeoxycholic Acid - adverse effects | Non-alcoholic Fatty Liver Disease - enzymology | Cholesterol, LDL - metabolism | Female | Clinical trials | Liver cirrhosis | Analysis | Deoxycholic acid | Liver diseases | Acids | Biopsy | Liver | Mortality | Ligands | Histology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents: The TONIC Randomized Controlled Trial
by Lavine, Joel E and Schwimmer, Jeffrey B and Van Natta, Mark L and Molleston, Jean P and Murray, Karen F and Rosenthal, Philip and Abrams, Stephanie H and Scheimann, Ann O and Sanyal, Arun J and Chalasani, Naga and Tonascia, James and Ünalp, Aynur and Clark, Jeanne M and Brunt, Elizabeth M and Kleiner, David E and Hoofnagle, Jay H and Robuck, Patricia R and Nonalcoholic Steatohepatitis Clinical Research Network, for the and Nonalcoholic Steatohepatitis Clini and Nonalcoholic Steatohepatitis Clinical Research Network
JAMA, ISSN 0098-7484, 04/2011, Volume 305, Issue 16, pp. 1659 - 1668
CONTEXT Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in US children and adolescents and can present with advanced fibrosis... 
MEDICINE, GENERAL & INTERNAL | STEATOHEPATITIS | THERAPY | HISTOPATHOLOGY | Hypoglycemic Agents - therapeutic use | Severity of Illness Index | Obesity | Metformin - therapeutic use | Double-Blind Method | Humans | Male | Treatment Outcome | Alanine Transaminase - blood | Fatty Liver - drug therapy | Antioxidants - therapeutic use | Adolescent | Fatty Liver - enzymology | Non-alcoholic Fatty Liver Disease | Vitamin E - therapeutic use | Female | Child | Clinical trials | Teenagers | Liver diseases | Vitamin E | Children & youth
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights